Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | FAAH | O00519 | 2/20 | 0.76 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.70 |
| ▸ | LHCGR | P22888 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21618461 | 1.00 | ALDH1A1 (1.00) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL8393776 | 1.00 | ALDH1A1 (1.00) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| Bicarbonate SCHEMBL15226094 | 0.98 | ALDH1A1 (0.97) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL5115600 | 0.98 | ALDH1A1 (0.97) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL8395644 | 0.95 | ALDH1A1 (0.90) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL9265423 | 0.94 | ALDH1A1 (0.88) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL1890946 | 0.91 | ALDH1A1 (0.83) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL1690686 | 0.91 | ALDH1A1 (0.82) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL530169 | 0.87 | FAAH (1.00) | ALDH1A1RAB9AFAAHLHCGR | |
| SCHEMBL10089405 | 0.87 | ALDH1A1 (0.76) | ALDH1A1RAB9AFAAHEPHX1LHCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1616859-B1 | Substituted cyclohexyl carboxylic acid compounds | SEIKAGAKU KOGYO CO LTD (JP) | 2013-09-04 | — | — | EP | claimed |
| US-20240308976-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND USES THEREOF | MONTE ROSA THERAPEUTICS AG (CH) | 2024-09-19 | — | — | US | disclosed |
| CN-116947604-A | Method for preparing 1, 4-cyclohexanediol from lignocellulose | 北京林业大学 | 2023-10-27 | — | — | CN | disclosed |
| US-20230257357-A1 | PROBENECID COMPOUNDS FOR THE TREATMENT OF INFLAMMASOME-MEDIATED LUNG DISEASE | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2023-08-17 | — | — | US | disclosed |
| CN-116035949-A | Oil balance type low-turbidity high-compatibility cosmetic composition | 上海永熙信息科技有限公司 | 2023-05-02 | — | — | CN | disclosed |
| WO-2023069708-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND USES THEREOF | MONTE ROSA THERAPEUTICS, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| CN-112020493-B | Method for producing urethane and method for producing isocyanate | 旭化成株式会社 | 2023-04-21 | — | — | CN | disclosed |
| WO-2022005881-A1 | PROBENECID COMPOUNDS FOR THE TREATMENT OF INFLAMMASOME-MEDIATED LUNG DISEASE | BACAINN BIOTHERAPEUTICS, INC. (US) | 2022-01-06 | — | — | WO | disclosed |
| CN-110546135-B | Method for producing isocyanate | 旭化成株式会社 | 2021-12-14 | — | — | CN | disclosed |
| CN-112020493-A | Method for producing carbamate and method for producing isocyanate | 旭化成株式会社 | 2020-12-01 | — | — | CN | disclosed |
| EP-2202220-A1 | ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF | Fujifilm Corporation (JP) | 2010-06-30 | — | — | EP | disclosed |
| US-20100009971-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound | ASTELLAS PHARMA INC. (JP) | 2010-01-14 | — | — | US | disclosed |
| US-20100009972-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound | ASTELLAS PHARMA INC. (JP) | 2010-01-14 | — | — | US | disclosed |
| US-20080306046-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative | FMC CORPORATION (US) | 2008-12-11 | — | — | US | disclosed |
| CN-101160287-A | Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative | ASTELLAS PHARMA INC (JP) | 2008-04-09 | — | — | CN | disclosed |
| EP-1849773-A1 | PYRIDYL NON-AROMATIC NITROGENATED HETEROCYCLIC-1-CARBOXYLATE ESTER DERIVATIVE | Astellas Pharma Inc. (JP) | 2007-10-31 | — | — | EP | disclosed |
| US-5864043-A | CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST | KARL THOMAE GMBH (DE) | 1999-01-26 | — | — | US | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |
| US-4451406-A | N-Substituted imido-dicarboxylic acid diaryl ester method of preparation | BAYER AKTIENGESELLSCHAFT (DE) | 1984-05-29 | — | — | US | disclosed |
| US-4447635-A | N-Substituted imido-dicarboxylic acid diaryl ester compounds and herbicide intermediates | BAYER AKTIENGESELLSCHAFT (DE) | 1984-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257357-A1 | PROBENECID COMPOUNDS FOR THE TREATMENT OF INFLAMMASOME-MEDIATED LUNG DISEASE | NLRP3, PYCARD, NLRP1 | ALDH1A1 1247/4885RAB9A 2771/4885FAAH 2515/4885 |
| US-20080306046-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative | FAAH, FAAH2, APEH | ALDH1A1 113/4885RAB9A 2309/4885FAAH 1/4885 |
| US-20100009972-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound | FAAH, FAAH2, CNR2 | ALDH1A1 133/4885RAB9A 1393/4885FAAH 1/4885 |
| US-20240308976-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND USES THEREOF | CRBN, GSPT1, GSPT2 | ALDH1A1 4088/4885RAB9A 1848/4885FAAH 3282/4885 |
| US-20100009971-A1 | Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Compound | FAAH, FAAH2, CNR1 | ALDH1A1 134/4885RAB9A 1416/4885FAAH 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.